公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study | Su, Yung-Yeh; Chiang, Nai-Jung; Li, Chung-Pin; Yen, Chia-Jui; SHIH-HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chuang, Shih-Chang; Bai, Li-Yuan; Chiu, Chang-Fang; Peng, Cheng-Ming; Chan, De-Chuan; Chiu, Sz-Chi; Yang, Yi-Hsin; Shan, Yan-Shen; Chen, Li-Tzong | Frontiers in oncology | 3 | 3 | |
2022 | Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin | Chiu, Tai-Jan; SHIH-HUNG YANG ; Chiu, Sz-Chi; Hsueh, Shun-Wen; Chiang, Nai-Jung; Li, Chung-Pin; Bai, Li-Yuan; Cheng, Fu-Ming; Chuang, Shih-Chang; Shan, Yan-Shen; Chan, De-Chuan; Chen, Li-Tzong; Yen, Chia-Jui; Peng, Cheng-Ming; Su, Yung-Yeh; Chen, Yen-Yang; Chen, Jen-Shi; Chou, Wen-Chi | Journal of hepato-biliary-pancreatic sciences | 2 | 2 | |
2017 | A phase II trial of regorafenib in patients with metastatic and/ or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 | Yeh, Chun-Nan; Chen, Ming-Huang; Chen, Yen-Yang; CHING-YAO YANG ; Yen, Chueh-Chuan; Tzen, Chin-Yuan; Chen, Li-Tzong; YEN-YANG CHEN | Oncotarget | 47 | 43 | |
2023 | Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer | Su, Yung-Yeh; Chiang, Nai-Jung; Yang, Yi-Hsin; Yen, Chia-Jui; Bai, Li-Yuan; Chiu, Chang-Fang; Chuang, Shih-Chang; SHIH HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chan, De-Chuan; Peng, Cheng-Ming; Chiu, Sz-Chi; Li, Chung-Pin; Shan, Yan-Shen; Chen, Li-Tzong | Cancers | 2 | 0 | |